Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Sissie Hsaio, the Google exec who oversaw the launch of the company’s AI chatbot, is stepping down as head of the Gemini app, ...
Google reshuffles AI leadership with Sissie Hsiao stepping down and Josh Woodward stepping in to drive Gemini's evolution.
On the heels of releasing its most capable AI model yet, Google is making some changes to the Gemini team. A new report from ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Explore more
Google has replaced the head of its consumer AI division, with Sissie Hsiao stepping down and Josh Woodward taking over. This ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results